Below are the five companies in the Biotechnology industry with the highest Enterprise Value (EV) to Forward EBITDA ratios. EV/Forward EBITDA is an important metric used in valuing comparable companies and is based on estimated cash flow. It is capital structure neutral and generally the lower the ratio, the more undervalued the company is believed to be. BioMarin Pharmaceutical (NASDAQ:BMRN) has the highest with EV/Forward EBITDA of 39.03x; Cepheid (NASDAQ:CPHD) is next with EV/Forward EBITDA of 36.02x; and Genomic Health (NASDAQ:GHDX) has the next highest with EV/Forward EBITDA of 27.06x. Alexion Pharmaceuticals (NASDAQ:ALXN) follows with EV/Forward EBITDA of 25.24x and Dendreon (NASDAQ:DNDN) rounds out the group with EV/Forward EBITDA of 20.01x. SmarTrend currently has shares of Cepheid in an Uptrend and issued the Uptrend alert on September 03, 2010 at $17.38. The stock has risen 64.2% since the Uptrend alert was issued.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac... -
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma... -
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th... -
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after... -
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y... -
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ... -
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment